Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Assets (2019 - 2025)

Bioadaptives' Assets history spans 7 years, with the latest figure at $225901.0 for Q4 2025.

  • Quarterly results put Assets at $225901.0 for Q4 2025, down 13.74% from a year ago — trailing twelve months through Dec 2025 was $225901.0 (down 13.74% YoY), and the annual figure for FY2025 was $225901.0, down 13.74%.
  • Assets for Q4 2025 was $225901.0 at Bioadaptives, up from $124360.0 in the prior quarter.
  • In the past five years, Assets ranged from a high of $329302.0 in Q3 2023 to a low of $8735.0 in Q2 2024.
  • The 5-year median for Assets is $107223.0 (2023), against an average of $120603.2.
  • The sharpest move saw Assets tumbled 85.91% in 2024, then skyrocketed 3019.81% in 2025.
  • Year by year, Assets stood at $148585.0 in 2021, then crashed by 74.89% to $37314.0 in 2022, then skyrocketed by 178.71% to $103998.0 in 2023, then skyrocketed by 151.82% to $261885.0 in 2024, then dropped by 13.74% to $225901.0 in 2025.
  • According to Business Quant data, Assets over the past three periods came in at $225901.0, $124360.0, and $272515.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.